Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rougier

Showing results (311-320 of 418) with videos related to

Pageof 42
Sort By:
Oncology|January 1, 1992
Phase II trial of 7-day continuous 5-fluorouracil infusion in the treatment of advanced colorectal carcinomaP Rougier, H Ammarguellat, M Ghosn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancerM Ducreux, M Ychou, J F Seitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative GroupsH Bartelink, F Roelofsen, F Eschwege, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Determination of the optimal dose of 5-fluorouracil when combined with low dose D,L-leucovorin and irradiation in rectal cancer: results of three consecutive phase II studies. EORTC Radiotherapy GroupJ F Bosset, J J Pavy, H P Hamers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Surgery for lung metastases from colorectal cancer: analysis of prognostic factorsP Girard, M Ducreux, P Baldeyrou, et al.
Transplantation|August 1, 1991
Effect of anti-LFA1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantationB Le Mauff, M Hourmant, J P Rougier, et al.
European Journal of Nuclear Medicine|January 1, 1987
Radiolabelled monoclonal antibodies against alpha-fetoprotein for in vivo localization of human hepatocellular carcinoma by immunotomoscintigraphyJ F Bergmann, J D Lumbroso, L Manil, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysisP Rougier, M Ducreux, M Mahjoubi, et al.
Bulletin Du Cancer|January 1, 1983
[Treatment of advanced colonic and rectal adenocarcinoma: combination of 5-FU and high-dose folinic acid]P Rougier, J P Droz, M Ducreux, et al.
American Journal of Clinical Oncology|April 25, 2000
Randomized comparison of prophylactic antidiarrheal treatment versus no prophylactic antidiarrheal treatment in patients receiving CPT-11 (irinotecan) for advanced 5-FU-resistant colorectal cancer: an open-label multicenter phase II studyM Ychou, J Y Douillard, P Rougier, et al.
Pageof 42

Showing results (311-320 of 418) with videos related to

Sort By:
Pageof 42
Oncology|January 1, 1992
Phase II trial of 7-day continuous 5-fluorouracil infusion in the treatment of advanced colorectal carcinomaP Rougier, H Ammarguellat, M Ghosn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancerM Ducreux, M Ychou, J F Seitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative GroupsH Bartelink, F Roelofsen, F Eschwege, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Determination of the optimal dose of 5-fluorouracil when combined with low dose D,L-leucovorin and irradiation in rectal cancer: results of three consecutive phase II studies. EORTC Radiotherapy GroupJ F Bosset, J J Pavy, H P Hamers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Surgery for lung metastases from colorectal cancer: analysis of prognostic factorsP Girard, M Ducreux, P Baldeyrou, et al.
Transplantation|August 1, 1991
Effect of anti-LFA1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantationB Le Mauff, M Hourmant, J P Rougier, et al.
European Journal of Nuclear Medicine|January 1, 1987
Radiolabelled monoclonal antibodies against alpha-fetoprotein for in vivo localization of human hepatocellular carcinoma by immunotomoscintigraphyJ F Bergmann, J D Lumbroso, L Manil, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysisP Rougier, M Ducreux, M Mahjoubi, et al.
Bulletin Du Cancer|January 1, 1983
[Treatment of advanced colonic and rectal adenocarcinoma: combination of 5-FU and high-dose folinic acid]P Rougier, J P Droz, M Ducreux, et al.
American Journal of Clinical Oncology|April 25, 2000
Randomized comparison of prophylactic antidiarrheal treatment versus no prophylactic antidiarrheal treatment in patients receiving CPT-11 (irinotecan) for advanced 5-FU-resistant colorectal cancer: an open-label multicenter phase II studyM Ychou, J Y Douillard, P Rougier, et al.
Pageof 42